A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

IsraelRecruitingPHASE3

Conditions

Huntington Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of CA San Diego, La Jolla, California, United States
Contact: Study coordinator (Krisha Bagga) · kbagga@health.ucsd.edu · +1 858 249 0574
Contact: Principal Investigator (Jody Corey-Bloom)
CenExcel Rocky Mtn Clin Research, Englewood, Colorado, United States
Contact: Study coordinator (Liza Heap) · e.heap@cenexel.com · +1 303 762 6674
Contact: Principal Investigator (Meagen Salinas)
Georgetown University, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Robin Kuprewicz) · rk1028@georgetown.edu
Contact: Principal Investigator (Karen Anderson)
Parkinsons-Movement Disorder Ctr, Chicago, Illinois, United States
Contact: Study coordinator (Zsa Zsa Brown) · zsazsa.brown@northwestern.edu · +1 312 503 5706
Contact: Principal Investigator (Danny Bega)
University of Kansas Hospital, Fairway, Kansas, United States
Contact: Study coordinator (Cameron Zoraghchi) · czoraghchi2@kumc.edu
Contact: Principal Investigator (Richard Dubinsky)
Albany Medical College, Albany, New York, United States
Contact: Study coordinator (Alicia Leader) · downeya@amc.edu · +1 518-262-5938
Contact: Principal Investigator (Era Kaur Hanspal)
UBMD Neurology, Buffalo, New York, United States
Contact: Study coordinator (Sonia Joseph) · joseph53@buffalo.edu · +1 716 932 6080
Contact: Principal Investigator (Kelly Andrzejewski)
Columbia University Irving Medical, New York, New York, United States
Contact: Study coordinator (Sandra Rizer) · sz2667@cumc.columbia.edu · +1 212 305 1718
Contact: Principal Investigator (Karen Marder)
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Contact: Study coordinator (Margaret Andorf) · andorfm@ccf.org · +1 216 442 5232
Contact: Principal Investigator (Adam Margolius)
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Gwenivere Toti) · gwenivere.toti@pennmedicine.upenn.edu
Contact: Principal Investigator (Aaron Lasker)
Veracity Neuroscience LLC, Memphis, Tennessee, United States
Contact: Study coordinator (Jennifer Marshall) · jennifer@veracityneuroscience.com · +1 901 237 3561
Contact: Principal Investigator (Mark Steven LeDoux)
TX Movement Disorder Spec PLLC, Georgetown, Texas, United States
Contact: Study coordinator (Wendy White) · wendy@txmds.net
Contact: Principal Investigator (Michael Soileau)
U of TX Health Science Ct, Houston, Texas, United States
Contact: Study coordinator (Dane Weinig) · Dane.R.Weinig@uth.tmc.edu · +1 832 325 7080
Contact: Principal Investigator (Erin Furr Stimming)
University of Washington Medical Center, Seattle, Washington, United States
Contact: Study coordinator (Debra Del Castillo) · debradel@uw.edu · +1 206 616 7117
Contact: Principal Investigator (Suman Jayadev)
North York General Hospital, North York, Ontario, Canada
Contact: Study coordinator (Clare Gibbons) · clare.gibbons@nygh.on.ca · +416 756 6788
Contact: Principal Investigator (Ragini Srinivasan, MD)
Centre de recherche du CHUM, Montreal, Quebec, Canada
Contact: Study coordinator (Martine Comeau) · martine.comeau.chum@ssss.gouv.qc.ca · +1514 890 8000
Contact: Principal Investigator (Alby Richard)
CUSM Montreal Neurological Institute, Montreal, Quebec, Canada
Contact: Study coordinator (Yara Nasr) · yara.nasr@mcgill.ca
Contact: Principal Investigator (Anne-Louise Lafontaine)
Novartis Investigative Site, Chengdu, Sichuan, China
Tel Aviv Sourasky Med Ctr Ichilov, Tel Aviv, Israel
Contact: Study coordinator (Tanya Gurevich) · tanyag@tlvmc.gov.il
Contact: Principal Investigator (Tanya Gurevich)
Novartis Investigative Site, Seoul, Seoul, South Korea
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Exeter, Devon, United Kingdom
Novartis Investigative Site, Aberdeen, Grampian Region, United Kingdom
Novartis Investigative Site, Cardiff, United Kingdom
Novartis Investigative Site, Glasgow, United Kingdom
University College Hospital, London, United Kingdom
Contact: Study coordinator (Kate Fayer) · k.fayer@ucl.ac.uk · 02031087483
Contact: Principal Investigator (Sarah Tabrizi)
Southampton General Hospital, Southampton, United Kingdom
Contact: Study coordinator (Giorgia Cortorillo) · giorgia.cortorillo@uhs.nhs.uk · 02381206132
Contact: Principal Investigator (Christopher Kipps)

View source on ClinicalTrials.gov Contact study team (email)